𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers

✍ Scribed by Valérie Martin; Stéphane Ribieras; Xiu-Gin Song-Wang; Yves Lasne; Lucien Frappart; Marie-Christine Rio; Robert Dante

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
189 KB
Volume
65
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

pS2 gene has been used to investigate the relationship between alterations of DNA methylation patterns in human tumors and gene expression. The expression of pS2, which is transcriptionally controlled by estrogens in breast cancer cell lines, is restricted to estrogen-receptor-rich human breast tumors. We found that the CCGG site within the promoter/enhancer sequence of pS2 was hypomethylated in estrogen-receptor-rich breast tumors expressing this gene. The amount of DNA molecules unmethylated at this site was related to the amount of pS2 mRNA detected in the samples. The demethylation of this region, which contains the estrogen responsive element, was confirmed by genomic sequencing. Transient expression of functional human estrogen receptors stimulated the expression of the endogenous pS2 in HeLa cells, but failed, in BT-20 cells, to stimulate expression of this gene. Since the promoter/enhancer region of pS2 is unmethylated in HeLa cells and methylated in BT-20 cells, these data also support the hypothesis that DNA methylation might be involved in the control of pS2 expression.

📜 SIMILAR VOLUMES

Expression of a breast-cancer-associated
Expression of a breast-cancer-associated protein (pS2) in human neuro-endocrine tumours
✍ Da-Gong Wang; Colin F. Johnston; Wei-Hua Liu; James M. Sloan; Keith D. Buchanan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 167 KB 👁 1 views

pS2 protein expression has been demonstrated in a range of malignant tissues in an oestrogen-independent pathway. Recently, it has been demonstrated that pS2, in prostate cancer, is closely associated with neuro-endocrine differentiation. In the present study, we have analyzed, by immunohistochemist

Up-regulation of the protein tyrosine ph
Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression
✍ Sonia S. Yip; A. Jayne Crew; Julia M.W. Gee; Rina Hui; Roger W. Blamey; John F.R 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB 👁 1 views

The protein tyrosine phosphatase SHP-1 is predominantly expressed in hemopoietic cell lineages, where its function is relatively well defined. However, its expression profile also extends to certain epithelial cell types. Furthermore, the negative regulatory role of this enzyme in hemopoietic cell s

An immunochemical analysis of mdm2 expre
An immunochemical analysis of mdm2 expression in human breast cancer and the identification of a growth-regulated cross-reacting species p170
✍ O'Neill, Mary; Campbell, Sandra J.; Save, Vicki; Thompson, Alastair M.; Hall, Pe 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 1 views

mdm2 is a 491 amino acid nuclear protein which is involved in complex interactions with important cell-cycle and stress-response regulators including p53, Rb and E2F. Recent data implicate mdm2 in the regulation of both p53 activity and level, and burgeoning data suggest that mdm2 may be involved in

An immunohistochemical examination of th
An immunohistochemical examination of the expression of E-cadherin, ?- and ?/?-catenins, and ?2- and ?1-integrins in invasive breast cancer
✍ Gonzalez, M. A.; Pinder, S. E.; Wencyk, P. M.; Bell, J. A.; Elston, C. W.; Nicho 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB 👁 1 views

This study examines the expression of the cell-cell adhesion molecules E-cadherin and its associated proteins, the catenins and the matrix-cell adhesion molecules 1-and 2-integrins, in primary invasive breast carcinoma. Expression was assessed immunohistochemically on frozen sections by semi-quantit

Comparison of the metastasis-inducing pr
Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer
✍ Angela M. Platt-Higgins; Christine A. Renshaw; Christopher R. West; John H.R. Wi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 293 KB

Our aim was to compare the occurrence and prognostic significance over 14 -20 years of immunocytochemically detected S100A4 and other tumour variables in primary tumours from 349 patients with operable breast cancer. For a cut-off of 1% staining of the malignant cells, the antibody to S100A4 stains